Here, we present h-Prune as a potential novel marker for the detection of early stage NSCLC, not only through its mRNA expression levels in lung cancer tissues as demonstrated by gene expression data, but also because of its secreted characteristic into peripheral blood. This evidence concerns the gene PRUNE1 and lung carcinoma.